1. Cathepsin L plays a key role in SARS-CoV-2 infection in humans and humanized mice and is a promising target for new drug development
- Author
-
Jin-Kui Yang, Li Zhang, Youchun Wang, Fang-Yuan Yang, Wei Hou, Yingmei Feng, Changfa Fan, Wei-Li Yang, Rong-Hua Jin, Miao-Miao Zhao, and Weijin Huang
- Subjects
0301 basic medicine ,Genetically modified mouse ,Adult ,Male ,Cancer Research ,Adolescent ,Transgene ,Cathepsin L ,lcsh:Medicine ,Mice, Transgenic ,Biology ,Cysteine Proteinase Inhibitors ,Antiviral Agents ,Article ,03 medical and health sciences ,Mice ,0302 clinical medicine ,Drug Development ,Viral entry ,In vivo ,Genetics ,medicine ,Animals ,Humans ,lcsh:QH301-705.5 ,Aged ,Gene knockdown ,SARS-CoV-2 ,lcsh:R ,Amantadine ,COVID-19 ,Middle Aged ,Virus Internalization ,Virology ,In vitro ,COVID-19 Drug Treatment ,030104 developmental biology ,Drug development ,Drug screening ,lcsh:Biology (General) ,Spike Glycoprotein, Coronavirus ,Cancer research ,biology.protein ,Infectious diseases ,Female ,Infection ,030217 neurology & neurosurgery ,medicine.drug - Abstract
SUMMARYTo discover new drugs to combat coronavirus disease 2019 (COVID-19), an understanding of the molecular basis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is urgently needed. Here, for the first time, we report the crucial role of cathepsin L (CTSL) in patients with COVID-19. The circulating level of CTSL was elevated and was positively correlated with disease course and severity in COVID-19 patients. Correspondingly, SARS-CoV-2 pseudovirus infection increasedCTSLexpression in human cell lines and humanACE2transgenic mice, whileCTSLoverexpression, in turn, enhanced pseudovirus infection. CTSL functionally cleaved the SARS-CoV-2 spike protein and enhanced virus entry, as evidenced by CTSL overexpression and knockdownin vitroand application of CTSL inhibitor drugsin vivo. Furthermore, amantadine, a licensed anti-influenza drug, significantly inhibited CTSL activity and prevented SARS-CoV-2 pseudovirus infection. Therefore, CTSL is a promising target for new anti-COVID-19 drug development.
- Published
- 2021